Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2021
The Asia Pacific market for CRM devices will expand through 2029, driven primarily by an aging population, the increasing prevalence of sedentary lifestyles and unhealthy diets, and the introduction of more advanced technology. The uptake of premium-priced devices such as MRI-conditional devices, leadless pacemakers, and S-ICDs will also boost revenues. However, the COVID-19 global pandemic will have a negative impact on the Asia Pacific CRM device market, resulting in lost procedure volumes in the short term followed by a period of recovery.
This Medtech 360 Report provides key market metrics for the CRM devices in Asia Pacific markets, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region, across a 10-year period.
